ADHD Trial, Recruiting NCT05034172 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: ADHD
Back to Adhd

ADHD Trial, Recruiting

NCT05034172
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Patients with inherited hyperkinetic movement disorders:

  • Any person aged 7 or older, male or female, who has been clinically diagnosed with an inherited hyperkinetic movement disorder (a type of condition causing uncontrolled movements that is passed down in families), with or without a confirmed genetic diagnosis
  • People with or without a family history of the condition may be eligible
  • Consent must be signed by the patient, both parents (for children), or a legal guardian where applicable
  • Participants must be covered by a social security or health insurance system

People considered "at risk" (no symptoms yet):

  • Adults aged 18 or older, male or female, who are a direct family member (parent, child, or sibling) of someone with an inherited hyperkinetic movement disorder
  • Adults aged 18 or older who carry a known gene change linked to one of these conditions
  • People in this group must have a normal neurological examination based on condition-specific assessments
  • Consent must be signed by the participant or their legal guardian

Healthy volunteers (control group):

  • Adults aged 18 or older, male or female, with no known neurological condition and no significant neurological symptoms
  • Consent must be signed by the participant

For optional skin biopsy (additional procedure, not required):

  • Participants must be aged 10 or older and able to undergo a minor skin biopsy procedure

For optional MRI scan (additional procedure, not required):

  • Participants must be able to undergo an MRI scan

Who may not be able to join:

  • People who are currently detained or imprisoned by a legal or judicial decision
  • People who are unable to have an MRI scan due to certain medical devices or conditions — this includes metal implants, pacemakers, artificial heart valves, certain brain or blood vessel conditions, aneurysm clips, metal fragments in the body, nerve or muscle stimulators, insulin pumps, certain intravenous devices, epilepsy, metal contraceptive devices, or claustrophobia (this applies only to the optional MRI part of the study)
  • People taking blood-thinning medications (anticoagulants or antiplatelet drugs) may not be eligible for the optional skin biopsy
  • People with a history of bleeding or clotting disorders may not be eligible for the optional skin biopsy
  • People who show a bleeding risk on a clotting test may not be eligible for the optional skin biopsy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 142161347

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
25 August 2021
Est. completion
25 August 2031

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Genetic entities among rare movement disorders: Pathology characterization (clinical spectrum) and its natural history: clinical Biomarkers; Genetic entities among rare movement disorders: Pathology characterization (clinical spectrum) and its natural history : genetic Biomarkers; Genetic entities among rare movement disorders: Pathology characterization (clinical spectrum) and its natural history : biological and/or imaging Biomarkers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov